SenzaGen AB 2021 AR2
The report highlights SenzaGen's financial and operational performance for the fiscal year 2021, during which net sales nearly doubled to SEK 15.4 million. A key milestone was the acquisition of Italy-based VitroScreen, which expanded the company's non-animal testing offering and market reach. Additionally, the ESAC issued a positive opinion on the GARDskin test method, recommending its adoption by the OECD. On the sustainability front, SenzaGen conducted a situation analysis based on ISO 26000 principles and implemented a Group-wide code of conduct.
Company: SenzaGen AB
Sector: Professional & technical services
Country: Sweden
Year: 2021
Type: AR2
Pages: 34
Back to company
SenzaGen AB
Annual Report
The report highlights SenzaGen's financial and operational performance for the fiscal year 2021, during which net sales nearly doubled to SEK 15.4 million. A key milestone was the acquisition of Italy-based VitroScreen, which expanded the company's non-animal testing offering and market reach. Additionally, the ESAC issued a positive opinion on the GARDskin test method, recommending its adoption by the OECD. On the sustainability front, SenzaGen conducted a situation analysis based on ISO 26000 principles and implemented a Group-wide code of conduct.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees